{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:56:30Z","timestamp":1790895390085,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006742","name":"School of Public Health, Tehran University of Medical Sciences, Tehran, Iran","doi-asserted-by":"publisher","award":["24155"],"award-info":[{"award-number":["24155"]}],"id":[{"id":"10.13039\/100006742","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004160","name":"School of Medicine, Mazandaran University of Medical Sciences","doi-asserted-by":"publisher","award":["980"],"award-info":[{"award-number":["980"]}],"id":[{"id":"10.13039\/501100004160","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal de Mycologie M\u00e9dicale"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.mycmed.2016.01.002","type":"journal-article","created":{"date-parts":[[2016,3,2]],"date-time":"2016-03-02T16:29:03Z","timestamp":1456936143000},"page":"116-121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["In vitro activities of five antifungal agents against 199 clinical and environmental isolates of Aspergillus flavus, an opportunistic fungal pathogen"],"prefix":"10.1016","volume":"26","author":[{"given":"S.","family":"Khodavaisy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Badali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.J.","family":"Hashemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Aala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Nazeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Nouripour-Sisakht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.S.","family":"Sorkherizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Amirizad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Aslani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Rezaie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mycmed.2016.01.002_bib0145","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/BF00437427","article-title":"Prevalence of airborne Aspergillus flavus in Khartoum (Sudan) airspora with reference to dusty weather and inoculum survival in simulated summer conditions","volume":"104","author":"Abdalla","year":"1988","journal-title":"Mycopathologia"},{"key":"10.1016\/j.mycmed.2016.01.002_bib0150","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/1471-2334-13-126","article-title":"Molecular identification and antifungal susceptibility profile of Aspergillus flavus isolates recovered from clinical specimens in Kuwait","volume":"13","author":"Al-Wathiqi","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.mycmed.2016.01.002_bib0155","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ijantimicag.2006.09.019","article-title":"Susceptibility of environmental versus clinical strains of pathogenic Aspergillus","volume":"29","author":"Araujo","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.mycmed.2016.01.002_bib0160","doi-asserted-by":"crossref","unstructured":"Badali H, Fakhim H, Zarei F, Nabili M, Vaezi A, Poorzad N, et al. In vitro activities of five antifungal drugs against opportunistic agents of Aspergillus Nigri complex. Mycopathologia. http:\/\/dx.doi.org\/10.1007\/s11046-015-9968-0.","DOI":"10.1007\/s11046-015-9968-0"},{"key":"10.1016\/j.mycmed.2016.01.002_bib0285","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/myc.12089","article-title":"Environmental study of azole-resistant Aspergillus fumigatus with TR34\/L98H mutations in the cyp51A gene in Iran","volume":"56","author":"Badali","year":"2013","journal-title":"Mycoses"},{"key":"10.1016\/j.mycmed.2016.01.002_bib0170","series-title":"Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; Approved Standard\u00a0\u2013\u00a0Second Edition. CLSI document M38-A2","author":"CLSI","year":"2008"},{"key":"10.1016\/j.mycmed.2016.01.002_bib0175","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1086\/317487","article-title":"Burden of aspergillosis-related hospitalizations in the United States","volume":"31","author":"Dasbach","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mycmed.2016.01.002_bib0180","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1093\/clinids\/12.6.1147","article-title":"Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases","volume":"12","author":"Denning","year":"1990","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.mycmed.2016.01.002_bib0185","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0196-4399(01)80005-2","article-title":"Clinical relevance of fungal susceptibility testing and antifungal resistance","volume":"22","author":"Espinel-Ingroff","year":"2000","journal-title":"Clin Microbiol Newsletter"},{"key":"10.1016\/j.mycmed.2016.01.002_bib0190","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1128\/JCM.00536-10","article-title":"Wild-type MIC distributions and epidemiological cutoff values for the triazoles and six Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document)","volume":"48","author":"Espinel-Ingroff","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.mycmed.2016.01.002_bib0195","doi-asserted-by":"crossref","first-page":"5150","DOI":"10.1128\/AAC.00686-11","article-title":"Wild-type MIC distributions and epidemiological cutoff values for amphotericin B and Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document)","volume":"55","author":"Espinel-Ingroff","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2016.01.002_bib0200","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1128\/AAC.01730-10","article-title":"Wild-type MIC distributions and epidemiological cutoff values for caspofungin and Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document)","volume":"55","author":"Espinel-Ingroff","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2016.01.002_bib0205","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1128\/AAC.00636-13","article-title":"Multicenter study of isavuconazole MIC distributions and epidemiological cutoff values for Aspergillus spp. for the CLSI M38-A2 broth microdilution method","volume":"57","author":"Espinel-Ingroff","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2016.01.002_bib0210","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1128\/AAC.01902-12","article-title":"In vitro antifungal susceptibility of clinically relevant species belonging to Aspergillus section Flavi","volume":"57","author":"Gon\u00e7alves","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2016.01.002_bib0215","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1128\/AAC.01512-07","article-title":"In vitro antifungal activities of isavuconazole (BAL4815), voriconazole, and fluconazole against 1,007 isolates of zygomycete, Candida, Aspergillus, Fusarium, and Scedosporium species","volume":"52","author":"Guinea","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2016.01.002_bib0220","first-page":"19","article-title":"Survey of airborne culturable and non-culturable fungi at different sites in Delhi metropolis","volume":"11","author":"Gupta","year":"2011","journal-title":"Asian Pac J Allergy Immunol"},{"key":"10.1016\/j.mycmed.2016.01.002_bib0225","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1099\/mic.0.2007\/007641-0","article-title":"Aspergillus flavus: human pathogen, allergen and mycotoxin producer","volume":"153","author":"Hedayati","year":"2007","journal-title":"Microbiology"},{"key":"10.1016\/j.mycmed.2016.01.002_bib0290","doi-asserted-by":"crossref","first-page":"52","DOI":"10.14712\/18059694.2014.24","article-title":"Invasive aspergillosis in intensive care unit patients in Iran","volume":"56","author":"Hedayati","year":"2013","journal-title":"Acta Medica (Hradec Kralove)"},{"key":"10.1016\/j.mycmed.2016.01.002_bib0230","doi-asserted-by":"crossref","DOI":"10.1111\/myc.12451","article-title":"Genotyping of clinical and environmental Aspergillus flavus isolates from Iran using microsatellites","author":"Khodavaisy","year":"2016","journal-title":"Mycoses"},{"key":"10.1016\/j.mycmed.2016.01.002_bib0235","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1439-0507.2008.01642.x","article-title":"Aspergillus flavus: an emerging non-fumigatus Aspergillus species of significance","volume":"52","author":"Krishnan","year":"2009","journal-title":"Mycoses"},{"key":"10.1016\/j.mycmed.2016.01.002_bib0240","first-page":"247","article-title":"Studies on air-borne fungi at Qena I.\u00a0Seasonal fluctuations","volume":"21","author":"Moubasher","year":"1981","journal-title":"Z Allg Mikrobiol"},{"key":"10.1016\/j.mycmed.2016.01.002_bib0245","first-page":"371","article-title":"Successful early voriconazole treatment of Aspergillus infection in two non immunocompromised patients in Intensive Care Unit","volume":"73","author":"Nataloni","year":"2007","journal-title":"Minerva Anestesiol"},{"key":"10.1016\/j.mycmed.2016.01.002_bib0250","doi-asserted-by":"crossref","first-page":"S261","DOI":"10.1080\/13693780802247702","article-title":"Differences in pathogenicity and clinical syndromes due to Aspergillus fumigatus and Aspergillus flavus","volume":"47","author":"Pasqualotto","year":"2008","journal-title":"Med Mycol"},{"key":"10.1016\/j.mycmed.2016.01.002_bib0255","doi-asserted-by":"crossref","first-page":"6615","DOI":"10.1128\/AAC.00637-15","article-title":"A novel Y319H mutation in CYP51C associated with azole resistance in Aspergillus flavus","volume":"59","author":"Paul","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2016.01.002_bib0260","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s00277-007-0292-8","article-title":"Successful treatment with voriconazole of Aspergillus meningitis in a patient with acute myeloid leukemia","volume":"86","author":"Saitoh","year":"2007","journal-title":"Ann Hematol"},{"key":"10.1016\/j.mycmed.2016.01.002_bib0270","doi-asserted-by":"crossref","first-page":"e583","DOI":"10.1111\/j.1439-0507.2010.01996.x","article-title":"In vitro susceptibility of 188 clinical and environmental isolates of Aspergillus flavus for the new triazole isavuconazole and seven other antifungal drugs","volume":"54","author":"Shivaprakash","year":"2011","journal-title":"Mycoses"},{"key":"10.1016\/j.mycmed.2016.01.002_bib0275","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jinf.2012.08.003","article-title":"Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry","volume":"65","author":"Steinbach","year":"2012","journal-title":"J Infect"},{"key":"10.1016\/j.mycmed.2016.01.002_bib0280","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/525258","article-title":"Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America","volume":"46","author":"Walsh","year":"2008","journal-title":"Clin Infect Dis"}],"container-title":["Journal de Mycologie M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523316000068?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523316000068?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T05:16:47Z","timestamp":1761110207000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1156523316000068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S1156523316000068"],"URL":"https:\/\/doi.org\/10.1016\/j.mycmed.2016.01.002","relation":{},"ISSN":["1156-5233"],"issn-type":[{"value":"1156-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro activities of five antifungal agents against 199 clinical and environmental isolates of Aspergillus flavus, an opportunistic fungal pathogen","name":"articletitle","label":"Article Title"},{"value":"Journal de Mycologie M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mycmed.2016.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}